Akebia Therapeutics Inc

Ticker AKBA

Exchange NASDAQ More
Industry Biotechnology More
Sector Healthcare More

201-500 Employees
Based in Cambridge, Massachussets

Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of proprietary therapeutics based on hypoxia inducible factor (HIF) biology for patients with kidney disease.

Visit website

Social Media Links

REPORT RATINGS

4.8 / 5.0 (208)

Akebia Therapeutics Inc reports have an aggregate usefulness score of 4.8 based on 208 reviews.

Akebia Therapeutics Inc

Most Recent Annual Report

MOST RECENT 2023 Annual Report and Form 10K

View PDF View Form 10K (HTML)

Akebia Therapeutics Inc does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Please fill out the form below and click "Place Order" to complete your order.